Global Paediatric Spasticity Treatment Market Size, Status and Forecast 2020-2026

August 2020 | 99 pages | ID: GAF3FECEB4C9EN
QYResearch

Abstracts

This report focuses on the global Paediatric Spasticity Treatment status, future forecast, growth opportunity, key market and key players. The study objectives are to present the Paediatric Spasticity Treatment development in North America, Europe and Asia-Pacific.
The key players covered in this study

• Allergan
• Ipsen Biopharmaceuticals
• Almirall
• Roche
• Sanofi
• Saol Therapeutics
• US WorldMeds

Market segment by Type, the product can be split into

• Drug Treatment
• Surgical Treatment

Market segment by Application, split into

• Hospital
• Clinic
• Emergency Sugical Center
• Others

Market segment by Regions/Countries, this report covers

• North America
• Europe
• Asia-Pacific

The study objectives of this report are:

• To analyze global Paediatric Spasticity Treatment status, future forecast, growth opportunity, key market and key players.
• To present the Paediatric Spasticity Treatment development in North America, Europe and Asia-Pacific.
• To strategically profile the key players and comprehensively analyze their development plan and strategies.
• To define, describe and forecast the market by type, market and key regions.

In this study, the years considered to estimate the market size of Paediatric Spasticity Treatment are as follows:

• History Year: 2015-2019
• Base Year: 2019
• Estimated Year: 2020
• Forecast Year 2020 to 2026

For the data information by region, company, type and application, 2019 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.

Contents

1 REPORT OVERVIEW

1.1 Study Scope
1.2 Key Market Segments
1.3 Players Covered: Ranking by Paediatric Spasticity Treatment Revenue
1.4 Market Analysis by Type
  1.4.1 Global Paediatric Spasticity Treatment Market Size Growth Rate by Type: 2020 VS 2026
  1.4.2 Drug Treatment
  1.4.3 Surgical Treatment
1.5 Market by Application
  1.5.1 Global Paediatric Spasticity Treatment Market Share by Application: 2020 VS 2026
  1.5.2 Hospital
  1.5.3 Clinic
  1.5.4 Emergency Sugical Center
  1.5.5 Others
1.6 Coronavirus Disease 2019 (Covid-19): Paediatric Spasticity Treatment Industry Impact
  1.6.1 How the Covid-19 is Affecting the Paediatric Spasticity Treatment Industry
    1.6.1.1 Paediatric Spasticity Treatment Business Impact Assessment - Covid-19
    1.6.1.2 Supply Chain Challenges
    1.6.1.3 COVID-19’s Impact On Crude Oil and Refined Products
  1.6.2 Market Trends and Paediatric Spasticity Treatment Potential Opportunities in the COVID-19 Landscape
  1.6.3 Measures / Proposal against Covid-19
    1.6.3.1 Government Measures to Combat Covid-19 Impact
    1.6.3.2 Proposal for Paediatric Spasticity Treatment Players to Combat Covid-19 Impact
1.7 Study Objectives
1.8 Years Considered

2 GLOBAL GROWTH TRENDS BY REGIONS

2.1 Paediatric Spasticity Treatment Market Perspective (2015-2026)
2.2 Paediatric Spasticity Treatment Growth Trends by Regions
  2.2.1 Paediatric Spasticity Treatment Market Size by Regions: 2015 VS 2020 VS 2026
  2.2.2 Paediatric Spasticity Treatment Historic Market Share by Regions (2015-2020)
  2.2.3 Paediatric Spasticity Treatment Forecasted Market Size by Regions (2021-2026)
2.3 Industry Trends and Growth Strategy
  2.3.1 Market Top Trends
  2.3.2 Market Drivers
  2.3.3 Market Challenges
  2.3.4 Porter’s Five Forces Analysis
  2.3.5 Paediatric Spasticity Treatment Market Growth Strategy
  2.3.6 Primary Interviews with Key Paediatric Spasticity Treatment Players (Opinion Leaders)

3 COMPETITION LANDSCAPE BY KEY PLAYERS

3.1 Global Top Paediatric Spasticity Treatment Players by Market Size
  3.1.1 Global Top Paediatric Spasticity Treatment Players by Revenue (2015-2020)
  3.1.2 Global Paediatric Spasticity Treatment Revenue Market Share by Players (2015-2020)
  3.1.3 Global Paediatric Spasticity Treatment Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.2 Global Paediatric Spasticity Treatment Market Concentration Ratio
  3.2.1 Global Paediatric Spasticity Treatment Market Concentration Ratio (CR5 and HHI)
  3.2.2 Global Top 10 and Top 5 Companies by Paediatric Spasticity Treatment Revenue in 2019
3.3 Paediatric Spasticity Treatment Key Players Head office and Area Served
3.4 Key Players Paediatric Spasticity Treatment Product Solution and Service
3.5 Date of Enter into Paediatric Spasticity Treatment Market
3.6 Mergers & Acquisitions, Expansion Plans

4 BREAKDOWN DATA BY TYPE (2015-2026)

4.1 Global Paediatric Spasticity Treatment Historic Market Size by Type (2015-2020)
4.2 Global Paediatric Spasticity Treatment Forecasted Market Size by Type (2021-2026)

5 PAEDIATRIC SPASTICITY TREATMENT BREAKDOWN DATA BY APPLICATION (2015-2026)

5.1 Global Paediatric Spasticity Treatment Market Size by Application (2015-2020)
5.2 Global Paediatric Spasticity Treatment Forecasted Market Size by Application (2021-2026)

6 NORTH AMERICA

6.1 North America Paediatric Spasticity Treatment Market Size (2015-2020)
6.2 Paediatric Spasticity Treatment Key Players in North America (2019-2020)
6.3 North America Paediatric Spasticity Treatment Market Size by Type (2015-2020)
6.4 North America Paediatric Spasticity Treatment Market Size by Application (2015-2020)

7 EUROPE

7.1 Europe Paediatric Spasticity Treatment Market Size (2015-2020)
7.2 Paediatric Spasticity Treatment Key Players in Europe (2019-2020)
7.3 Europe Paediatric Spasticity Treatment Market Size by Type (2015-2020)
7.4 Europe Paediatric Spasticity Treatment Market Size by Application (2015-2020)

8 ASIA-PACIFIC

8.1 Asia-Pacific Paediatric Spasticity Treatment Market Size (2015-2020)
8.2 Paediatric Spasticity Treatment Key Players in Asia-Pacific (2019-2020)
8.3 Asia-Pacific Paediatric Spasticity Treatment Market Size by Type (2015-2020)
8.4 Asia-Pacific Paediatric Spasticity Treatment Market Size by Application (2015-2020)
(2015-2020)
(2015-2020)

9 KEY PLAYERS PROFILES

9.1 Allergan
  9.1.1 Allergan Company Details
  9.1.2 Allergan Business Overview and Its Total Revenue
  9.1.3 Allergan Paediatric Spasticity Treatment Introduction
  9.1.4 Allergan Revenue in Paediatric Spasticity Treatment Business (2015-2020))
  9.1.5 Allergan Recent Development
9.2 Ipsen Biopharmaceuticals
  9.2.1 Ipsen Biopharmaceuticals Company Details
  9.2.2 Ipsen Biopharmaceuticals Business Overview and Its Total Revenue
  9.2.3 Ipsen Biopharmaceuticals Paediatric Spasticity Treatment Introduction
  9.2.4 Ipsen Biopharmaceuticals Revenue in Paediatric Spasticity Treatment Business (2015-2020)
  9.2.5 Ipsen Biopharmaceuticals Recent Development
9.3 Almirall
  9.3.1 Almirall Company Details
  9.3.2 Almirall Business Overview and Its Total Revenue
  9.3.3 Almirall Paediatric Spasticity Treatment Introduction
  9.3.4 Almirall Revenue in Paediatric Spasticity Treatment Business (2015-2020)
  9.3.5 Almirall Recent Development
9.4 Roche
  9.4.1 Roche Company Details
  9.4.2 Roche Business Overview and Its Total Revenue
  9.4.3 Roche Paediatric Spasticity Treatment Introduction
  9.4.4 Roche Revenue in Paediatric Spasticity Treatment Business (2015-2020)
  9.4.5 Roche Recent Development
9.5 Sanofi
  9.5.1 Sanofi Company Details
  9.5.2 Sanofi Business Overview and Its Total Revenue
  9.5.3 Sanofi Paediatric Spasticity Treatment Introduction
  9.5.4 Sanofi Revenue in Paediatric Spasticity Treatment Business (2015-2020)
  9.5.5 Sanofi Recent Development
9.6 Saol Therapeutics
  9.6.1 Saol Therapeutics Company Details
  9.6.2 Saol Therapeutics Business Overview and Its Total Revenue
  9.6.3 Saol Therapeutics Paediatric Spasticity Treatment Introduction
  9.6.4 Saol Therapeutics Revenue in Paediatric Spasticity Treatment Business (2015-2020)
  9.6.5 Saol Therapeutics Recent Development
9.7 US WorldMeds
  9.7.1 US WorldMeds Company Details
  9.7.2 US WorldMeds Business Overview and Its Total Revenue
  9.7.3 US WorldMeds Paediatric Spasticity Treatment Introduction
  9.7.4 US WorldMeds Revenue in Paediatric Spasticity Treatment Business (2015-2020)
  9.7.5 US WorldMeds Recent Development

10 ANALYST'S VIEWPOINTS/CONCLUSIONS

11 APPENDIX

11.1 Research Methodology
  11.1.1 Methodology/Research Approach
  11.1.2 Data Source
11.2 Disclaimer
11.3 Author Details

List Of Tables

LIST OF TABLES

Table 1. Paediatric Spasticity Treatment Key Market Segments
Table 2. Key Players Covered: Ranking by Paediatric Spasticity Treatment Revenue
Table 3. Ranking of Global Top Paediatric Spasticity Treatment Manufacturers by Revenue (US$ Million) in 2019
Table 4. Global Paediatric Spasticity Treatment Market Size Growth Rate by Type (US$ Million): 2020 VS 2026
Table 5. Key Players of Drug Treatment
Table 6. Key Players of Surgical Treatment
Table 7. COVID-19 Impact Global Market: (Four Paediatric Spasticity Treatment Market Size Forecast Scenarios)
Table 8. Opportunities and Trends for Paediatric Spasticity Treatment Players in the COVID-19 Landscape
Table 9. Present Opportunities in China & Elsewhere Due to the Coronavirus Crisis
Table 10. Key Regions/Countries Measures against Covid-19 Impact
Table 11. Proposal for Paediatric Spasticity Treatment Players to Combat Covid-19 Impact
Table 12. Global Paediatric Spasticity Treatment Market Size Growth by Application (US$ Million): 2020 VS 2026
Table 13. Global Paediatric Spasticity Treatment Market Size by Regions (US$ Million): 2020 VS 2026
Table 14. Global Paediatric Spasticity Treatment Market Size by Regions (2015-2020) (US$ Million)
Table 15. Global Paediatric Spasticity Treatment Market Share by Regions (2015-2020)
Table 16. Global Paediatric Spasticity Treatment Forecasted Market Size by Regions (2021-2026) (US$ Million)
Table 17. Global Paediatric Spasticity Treatment Market Share by Regions (2021-2026)
Table 18. Market Top Trends
Table 19. Key Drivers: Impact Analysis
Table 20. Key Challenges
Table 21. Paediatric Spasticity Treatment Market Growth Strategy
Table 22. Main Points Interviewed from Key Paediatric Spasticity Treatment Players
Table 23. Global Paediatric Spasticity Treatment Revenue by Players (2015-2020) (Million US$)
Table 24. Global Paediatric Spasticity Treatment Market Share by Players (2015-2020)
Table 25. Global Top Paediatric Spasticity Treatment Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Paediatric Spasticity Treatment as of 2019)
Table 26. Global Paediatric Spasticity Treatment by Players Market Concentration Ratio (CR5 and HHI)
Table 27. Key Players Headquarters and Area Served
Table 28. Key Players Paediatric Spasticity Treatment Product Solution and Service
Table 29. Date of Enter into Paediatric Spasticity Treatment Market
Table 30. Mergers & Acquisitions, Expansion Plans
Table 31. Global Paediatric Spasticity Treatment Market Size by Type (2015-2020) (Million US$)
Table 32. Global Paediatric Spasticity Treatment Market Size Share by Type (2015-2020)
Table 33. Global Paediatric Spasticity Treatment Revenue Market Share by Type (2021-2026)
Table 34. Global Paediatric Spasticity Treatment Market Size Share by Application (2015-2020)
Table 35. Global Paediatric Spasticity Treatment Market Size by Application (2015-2020) (Million US$)
Table 36. Global Paediatric Spasticity Treatment Market Size Share by Application (2021-2026)
Table 37. North America Key Players Paediatric Spasticity Treatment Revenue (2019-2020) (Million US$)
Table 38. North America Key Players Paediatric Spasticity Treatment Market Share (2019-2020)
Table 39. North America Paediatric Spasticity Treatment Market Size by Type (2015-2020) (Million US$)
Table 40. North America Paediatric Spasticity Treatment Market Share by Type (2015-2020)
Table 41. North America Paediatric Spasticity Treatment Market Size by Application (2015-2020) (Million US$)
Table 42. North America Paediatric Spasticity Treatment Market Share by Application (2015-2020)
Table 43. Europe Key Players Paediatric Spasticity Treatment Revenue (2019-2020) (Million US$)
Table 44. Europe Key Players Paediatric Spasticity Treatment Market Share (2019-2020)
Table 45. Europe Paediatric Spasticity Treatment Market Size by Type (2015-2020) (Million US$)
Table 46. Europe Paediatric Spasticity Treatment Market Share by Type (2015-2020)
Table 47. Europe Paediatric Spasticity Treatment Market Size by Application (2015-2020) (Million US$)
Table 48. Europe Paediatric Spasticity Treatment Market Share by Application (2015-2020)
Table 49. Asia-Pacific Key Players Paediatric Spasticity Treatment Revenue (2019-2020) (Million US$)
Table 50. Asia-Pacific Key Players Paediatric Spasticity Treatment Market Share (2019-2020)
Table 51. Asia-Pacific Paediatric Spasticity Treatment Market Size by Type (2015-2020) (Million US$)
Table 52. Asia-Pacific Paediatric Spasticity Treatment Market Share by Type (2015-2020)
Table 53. Asia-Pacific Paediatric Spasticity Treatment Market Size by Application (2015-2020) (Million US$)
Table 54. Asia-Pacific Paediatric Spasticity Treatment Market Share by Application (2015-2020)
Table 55. Allergan Company Details
Table 56. Allergan Business Overview
Table 57. Allergan Product
Table 58. Allergan Revenue in Paediatric Spasticity Treatment Business (2015-2020) (Million US$)
Table 59. Allergan Recent Development
Table 60. Ipsen Biopharmaceuticals Company Details
Table 61. Ipsen Biopharmaceuticals Business Overview
Table 62. Ipsen Biopharmaceuticals Product
Table 63. Ipsen Biopharmaceuticals Revenue in Paediatric Spasticity Treatment Business (2015-2020) (Million US$)
Table 64. Ipsen Biopharmaceuticals Recent Development
Table 65. Almirall Company Details
Table 66. Almirall Business Overview
Table 67. Almirall Product
Table 68. Almirall Revenue in Paediatric Spasticity Treatment Business (2015-2020) (Million US$)
Table 69. Almirall Recent Development
Table 70. Roche Company Details
Table 71. Roche Business Overview
Table 72. Roche Product
Table 73. Roche Revenue in Paediatric Spasticity Treatment Business (2015-2020) (Million US$)
Table 74. Roche Recent Development
Table 75. Sanofi Company Details
Table 76. Sanofi Business Overview
Table 77. Sanofi Product
Table 78. Sanofi Revenue in Paediatric Spasticity Treatment Business (2015-2020) (Million US$)
Table 79. Sanofi Recent Development
Table 80. Saol Therapeutics Company Details
Table 81. Saol Therapeutics Business Overview
Table 82. Saol Therapeutics Product
Table 83. Saol Therapeutics Revenue in Paediatric Spasticity Treatment Business (2015-2020) (Million US$)
Table 84. Saol Therapeutics Recent Development
Table 85. US WorldMeds Company Details
Table 86. US WorldMeds Business Overview
Table 87. US WorldMeds Product
Table 88. US WorldMeds Revenue in Paediatric Spasticity Treatment Business (2015-2020) (Million US$)
Table 89. US WorldMeds Recent Development
Table 90. Research Programs/Design for This Report
Table 91. Key Data Information from Secondary Sources
Table 92. Key Data Information from Primary Sources

List Of Figures

LIST OF FIGURES

Figure 1. Global Paediatric Spasticity Treatment Market Share by Type: 2020 VS 2026
Figure 2. Drug Treatment Features
Figure 3. Surgical Treatment Features
Figure 4. Global Paediatric Spasticity Treatment Market Share by Application: 2020 VS 2026
Figure 5. Hospital Case Studies
Figure 6. Clinic Case Studies
Figure 7. Emergency Sugical Center Case Studies
Figure 8. Others Case Studies
Figure 9. Paediatric Spasticity Treatment Report Years Considered
Figure 10. Global Paediatric Spasticity Treatment Market Size YoY Growth 2015-2026 (US$ Million)
Figure 11. Global Paediatric Spasticity Treatment Market Share by Regions: 2020 VS 2026
Figure 12. Global Paediatric Spasticity Treatment Market Share by Regions (2021-2026)
Figure 13. Porter's Five Forces Analysis
Figure 14. Global Paediatric Spasticity Treatment Market Share by Players in 2019
Figure 15. Global Top Paediatric Spasticity Treatment Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Paediatric Spasticity Treatment as of 2019
Figure 16. The Top 10 and 5 Players Market Share by Paediatric Spasticity Treatment Revenue in 2019
Figure 17. North America Paediatric Spasticity Treatment Market Size YoY Growth (2015-2020) (Million US$)
Figure 18. Europe Paediatric Spasticity Treatment Market Size YoY Growth (2015-2020) (Million US$)
Figure 19. Asia-Pacific Paediatric Spasticity Treatment Market Size YoY Growth (2015-2020) (Million US$)
Figure 20. Allergan Total Revenue (US$ Million): 2019 Compared with 2018
Figure 21. Allergan Revenue Growth Rate in Paediatric Spasticity Treatment Business (2015-2020)
Figure 22. Ipsen Biopharmaceuticals Total Revenue (US$ Million): 2019 Compared with 2018
Figure 23. Ipsen Biopharmaceuticals Revenue Growth Rate in Paediatric Spasticity Treatment Business (2015-2020)
Figure 24. Almirall Total Revenue (US$ Million): 2019 Compared with 2018
Figure 25. Almirall Revenue Growth Rate in Paediatric Spasticity Treatment Business (2015-2020)
Figure 26. Roche Total Revenue (US$ Million): 2019 Compared with 2018
Figure 27. Roche Revenue Growth Rate in Paediatric Spasticity Treatment Business (2015-2020)
Figure 28. Sanofi Total Revenue (US$ Million): 2019 Compared with 2018
Figure 29. Sanofi Revenue Growth Rate in Paediatric Spasticity Treatment Business (2015-2020)
Figure 30. Saol Therapeutics Total Revenue (US$ Million): 2019 Compared with 2018
Figure 31. Saol Therapeutics Revenue Growth Rate in Paediatric Spasticity Treatment Business (2015-2020)
Figure 32. US WorldMeds Total Revenue (US$ Million): 2019 Compared with 2018
Figure 33. US WorldMeds Revenue Growth Rate in Paediatric Spasticity Treatment Business (2015-2020)
Figure 34. Bottom-up and Top-down Approaches for This Report
Figure 35. Data Triangulation
Figure 36. Key Executives Interviewed